Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21WAF1/CIP1expression

Author:

Tseng Tsui-Hwa12,Chien Ming-Hsien34,Lin Wea-Lung5,Wen Yu-Ching6,Chow Jyh-Ming7,Chen Chi-Kuan8,Kuo Tsang-Chih9,Lee Wei-Jiunn410

Affiliation:

1. Department of Medical Applied Chemistry; Chung Shan Medical University; Taichung Taiwan

2. Department of Medical Education; Chung Shan Medical University Hospital; Taichung Taiwan

3. Graduate Institute of Clinical Medicine, College of Medicine; Taipei Medical University; Taipei Taiwan

4. Department of Medical Education and Research; Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

5. Department of Pathology; Chung Shan Medical University Hospital; Taichung Taiwan

6. Department of Urology; Wan Fang Hospital, Taipei Medical University; Taipei Taiwan

7. Division of Hematology and Medical Oncology, Department of Internal Medicine; Taipei Medical University, Wan Fang Hospital; Taipei Taiwan

8. Genomics Research Center, Academia Sinica; Taipei Taiwan

9. Institute of Biochemical Science, College of Life Science; National Taiwan University; Taipei Taiwan

10. Department of Urology, School of Medicine, College of Medicine; Taipei Medical University; Taipei Taiwan

Funder

Chung Shan Medical University Hospital.

National Science Council

Taipei Medical University-Wan Fang Hospital

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Management, Monitoring, Policy and Law,Toxicology,General Medicine

Reference41 articles.

1. Treatment and care of patients with metastatic breast cancer;Beaumont;Nurs Stand,2011

2. Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol;Birt;Carcinogenesis,1986

3. Dietary agents in cancer prevention: Flavonoids and isoflavonoids;Birt;Pharmacol Ther,2001

4. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity;Blagosklonny;Mol Cancer Ther,2002

5. Anticancer activities of histone deacetylase inhibitors;Bolden;Nat Rev Drug Discov,2006

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3